{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:17:18Z","timestamp":1790108238485,"version":"4.0.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T00:00:00Z","timestamp":1737590400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T00:00:00Z","timestamp":1737590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Medical Scientific Fund of the Mayor of the City of Vienna","award":["21040"],"award-info":[{"award-number":["21040"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-87027-2","type":"journal-article","created":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T02:43:42Z","timestamp":1737600222000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Characterization of a pleomorphic rhabdomyosarcoma cell line"],"prefix":"10.1038","volume":"15","author":[{"given":"Sandra","family":"Stickler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Rieche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Therese","family":"Eggerstorfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Hohenegger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Hochmair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,23]]},"reference":[{"issue":"6","key":"87027_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11864-015-0342-8","volume":"16","author":"C Ruiz-Mesa","year":"2015","unstructured":"Ruiz-Mesa, C., Goldberg, J. M., Munoz, C., Dumont, A. J., Trent, J. C. & S. N. & Rhabdomyosarcoma in adults: new perspectives on therapy. Curr. Treat. Opt. Oncol. 16(6), 27 (2015).","journal-title":"Curr. Treat. Opt. Oncol."},{"issue":"10","key":"87027_CR2","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.5858\/arpa.2014-0475-OA","volume":"139","author":"ER Rudzinski","year":"2015","unstructured":"Rudzinski, E. R. et al. The World Health Organization Classification of Skeletal Muscle Tumors in Pediatric Rhabdomyosarcoma: a Report from the children\u2019s Oncology Group. Arch. Pathol. Lab. Med. 139(10), 1281\u20131287 (2015).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"87027_CR3","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1097\/00000658-194603000-00011","volume":"123","author":"AP Stout","year":"1946","unstructured":"Stout, A. P. Rhabdomyosarcoma of the skeletal muscles. Ann. Surg. 123, 447\u2013472 (1946).","journal-title":"Ann. Surg."},{"issue":"1","key":"87027_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-018-0051-2","volume":"5","author":"SX Skapek","year":"2019","unstructured":"Skapek, S. X. et al. Nat. Rev. Dis. Primers 5(1), 1 (2019).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"87027_CR5","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/modpathol.3880357","volume":"14","author":"M Furlong","year":"2001","unstructured":"Furlong, M., Mentzel, T. & Fanburg-Smith, J. Pleomorphic rhabdomyosarcoma in adults: a clinicopathologic study of 38 cases with emphasis on morphologic variants and recent skeletal muscle-specific markers. Mod. Pathol. 14, 595\u2013603 (2001).","journal-title":"Mod. Pathol."},{"issue":"12","key":"87027_CR6","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1097\/PAS.0b013e3181be6209","volume":"33","author":"N Stock","year":"2009","unstructured":"Stock, N. et al. Adult-type rhabdomyosarcoma: analysis of 57 cases with clinicopathologic description, identification of 3 morphologic patterns and prognosis. Am. J. Surg. Pathol. 33(12), 1850\u20131859 (2009).","journal-title":"Am. J. Surg. Pathol."},{"issue":"11","key":"87027_CR7","first-page":"6213","volume":"35","author":"J Noujaim","year":"2015","unstructured":"Noujaim, J. et al. Adult pleomorphic rhabdomyosarcoma: a multicentre retrospective study. Anticancer Res. 35(11), 6213\u20136217 (2015).","journal-title":"Anticancer Res."},{"issue":"4","key":"87027_CR8","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1002\/cam4.92","volume":"2","author":"SN Dumont","year":"2013","unstructured":"Dumont, S. N. et al. Management and outcome of 239 adolescent and adult rhabdomyosarcoma patients. Cancer Med. 2(4), 553\u2013563 (2013).","journal-title":"Cancer Med."},{"issue":"21","key":"87027_CR9","doi-asserted-by":"publisher","first-page":"5269","DOI":"10.3390\/cancers15215269","volume":"15","author":"A Zarrabi","year":"2023","unstructured":"Zarrabi, A. et al. Rhabdomyosarcoma: current therapy, challenges, and future approaches to treatment strategies. Cancers (Basel). 15(21), 5269 (2023).","journal-title":"Cancers (Basel)"},{"issue":"12","key":"87027_CR10","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.1200\/JCO.2001.19.12.3091","volume":"19","author":"WM Crist","year":"2001","unstructured":"Crist, W. M. et al. Intergroup Rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease. J. Clin. Oncol. 19(12), 3091\u20133102 (2001).","journal-title":"J. Clin. Oncol."},{"issue":"20","key":"87027_CR11","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.1200\/JCO.2008.19.7483","volume":"27","author":"I Sultan","year":"2009","unstructured":"Sultan, I., Qaddoumi, I., Yaser, S., Rodriguez-Galindo, C. & Ferrari, A. Comparing adult and pediatric rhabdomyosarcoma in the surveillance, epidemiology and end results program, 1973 to 2005: an analysis of 2,600 patients. J. Clin. Oncol. 27(20), 3391\u20133397 (2009).","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"87027_CR12","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1002\/cncr.11550","volume":"98","author":"A Ferrari","year":"2003","unstructured":"Ferrari, A. et al. Rhabdomyosarcoma in adults. A retrospective analysis of 171 patients treated at a single institution. Cancer 98(3), 571\u2013580 (2003).","journal-title":"Cancer"},{"issue":"1","key":"87027_CR13","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3109\/01913120903353795","volume":"34","author":"B Eyden","year":"2010","unstructured":"Eyden, B. Pleomorphic rhabdomyosarcoma showing smooth-muscle and fibrohistiocytic differentiation: a single case report. Ultrastruct. Pathol. 34(1), 42\u201347 (2010).","journal-title":"Ultrastruct. Pathol."},{"key":"87027_CR14","doi-asserted-by":"crossref","unstructured":"Lychou, S. E., Gustafsson, G. G. & Ljungman, G. E. Higher rates of metastatic disease may explain the declining trend in Swedish paediatric rhabdomyosarcoma survival rates. Acta Paediatr. (Oslo, Norway: 1992) 105(1), 74\u201381 (2016)","DOI":"10.1111\/apa.13172"},{"issue":"1","key":"87027_CR15","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1365-3016.1994.tb00439.x","volume":"8","author":"CA Stiller","year":"1994","unstructured":"Stiller, C. A. & Parkin, D. M. International variations in the incidence of childhood soft-tissue sarcomas. Paediatr. Perinat. Epidemiol. 8(1), 107\u2013119 (1994).","journal-title":"Paediatr. Perinat. Epidemiol."},{"issue":"1","key":"87027_CR16","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1053\/j.sempedsurg.2011.10.007","volume":"21","author":"R Dasgupta","year":"2012","unstructured":"Dasgupta, R. & Rodeberg, D. A. Update on rhabdomyosarcoma. Semin. Pediatr. Surg. 21(1), 68\u201378 (2012).","journal-title":"Semin. Pediatr. Surg."},{"issue":"1","key":"87027_CR17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1080\/13577140120048890","volume":"5","author":"RB Raney","year":"2001","unstructured":"Raney, R. B. et al. Major lessons from the IRS-I through IRS-IV studies as background for the current IRS-V treatment protocols. Sarcoma 5(1), 9\u201315 (2001).","journal-title":"Sarcoma"},{"issue":"2","key":"87027_CR18","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s00280-016-3077-8","volume":"78","author":"E Kahen","year":"2016","unstructured":"Kahen, E. et al. Identification of clinically achievable combination therapies in childhood rhabdomyosarcoma. Cancer Chemother. Pharmacol. 78(2), 313\u2013323 (2016).","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"2","key":"87027_CR19","first-page":"535","volume":"42","author":"JA Houghton","year":"1982","unstructured":"Houghton, J. A., Houghton, P. J. & Green, A. A. Chemotherapy of childhood rhabdomyosarcomas growing as xenografts in immune-deprived mice. Cancer Res. 42(2), 535\u2013539 (1982).","journal-title":"Cancer Res."},{"issue":"3","key":"87027_CR20","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.ccell.2018.07.012","volume":"34","author":"E Stewart","year":"2018","unstructured":"Stewart, E. et al. Identification of therapeutic targets in rhabdomyosarcoma through integrated genomic, epigenomic, and proteomic analyses. Cancer Cell 34(3), 411\u2013426e19. https:\/\/doi.org\/10.1016\/j.ccell.2018.07.012 (2018).","journal-title":"Cancer Cell"},{"issue":"1","key":"87027_CR21","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ccell.2017.12.001","volume":"33","author":"CJ Drummond","year":"2018","unstructured":"Drummond, C. J. et al. Hedgehog pathway drives fusion-negative rhabdomyosarcoma initiated from non-myogenic endothelial progenitors. Cancer Cell. 33(1), 108\u2013124e5. https:\/\/doi.org\/10.1016\/j.ccell.2017.12.001 (2018).","journal-title":"Cancer Cell."},{"issue":"2","key":"87027_CR22","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/ng0293-113","volume":"3","author":"FG Barr","year":"1993","unstructured":"Barr, F. G. et al. Rearrangement of the PAX3 paired box gene in the paediatric solid tumour alveolar rhabdomyosarcoma. Nat. Genet. 3(2), 113\u2013117 (1993).","journal-title":"Nat. Genet."},{"issue":"8","key":"87027_CR23","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1158\/2159-8290.CD-16-1297","volume":"7","author":"BE Gryder","year":"2017","unstructured":"Gryder, B. E. et al. PAX3-FoxO1 establishes myogenic super enhancers and confers BET bromodomain vulnerability. Cancer Discov. 7(8), 884\u2013899 (2017).","journal-title":"Cancer Discov."},{"issue":"3","key":"87027_CR24","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1128\/MCB.15.3.1522","volume":"15","author":"WJ Fredericks","year":"1995","unstructured":"Fredericks, W. J. et al. The PAX3-FKHR fusion protein created by the t(2;13) translocation in alveolar rhabdomyosarcomas is a more potent transcriptional activator than PAX3. Mol. Cell. Biol. 15(3), 1522\u20131535 (1995).","journal-title":"Mol. Cell. Biol."},{"issue":"3","key":"87027_CR25","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1002\/1097-0142(196909)24:3<520::AID-CNCR2820240313>3.0.CO;2-M","volume":"24","author":"RM McAllister","year":"1969","unstructured":"McAllister, R. M., Melnyk, J., Finkelstein, J. Z., Adams Jr, E. C. & Gardner, M. B. Cultivation in vitro of cells derived from a human rhabdomyosarcoma. Cancer 24(3), 520\u2013526 (1969).","journal-title":"Cancer"},{"key":"87027_CR26","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3389\/fonc.2013.00183","volume":"3","author":"AR Hinson","year":"2013","unstructured":"Hinson, A. R. et al. Human rhabdomyosarcoma cell lines for Rhabdomyosarcoma research: utility and pitfalls. Front. Oncol. 3, 183 (2013).","journal-title":"Front. Oncol."},{"key":"87027_CR27","doi-asserted-by":"crossref","unstructured":"Stratton, M. R. et al. Characterization of the human cell line TE671. Carcinogenesis 10(5), 899\u2013905 (1989).","DOI":"10.1093\/carcin\/10.5.899"},{"issue":"2","key":"87027_CR28","first-page":"141","volume":"2","author":"E Takaoka","year":"2012","unstructured":"Takaoka, E. et al. Multiple sites of highly amplified DNA sequences detected by molecular cytogenetic analysis in HS-RMS-2, a new pleomorphic rhabdomyosarcoma cell line. Am. J. Cancer Res. 2(2), 141\u2013152 (2012).","journal-title":"Am. J. Cancer Res."},{"issue":"5","key":"87027_CR29","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1593\/neo.05829","volume":"8","author":"M Goldstein","year":"2006","unstructured":"Goldstein, M., Meller, I., Issakov, J. & Orr-Urtreger, A. Novel genes implicated in embryonal, alveolar, and pleomorphic rhabdomyosarcoma: a cytogenetic and molecular analysis of primary tumors. Neoplasia 8(5), 332\u2013343 (2006).","journal-title":"Neoplasia"},{"issue":"2","key":"87027_CR30","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1158\/2159-8290.CD-13-0639","volume":"4","author":"JF Shern","year":"2014","unstructured":"Shern, J. F. et al. Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors. Cancer Discov. 4(2), 216\u2013231 (2014).","journal-title":"Cancer Discov"},{"issue":"5","key":"87027_CR31","doi-asserted-by":"publisher","first-page":"e23238","DOI":"10.1002\/gcc.23238","volume":"63","author":"C Saoud","year":"2024","unstructured":"Saoud, C. et al. Genomic profiling of pleomorphic rhabdomyosarcoma reveals a genomic signature distinct from that of embryonal rhabdomyosarcoma. Genes Chromosomes Cancer 63(5), e23238. https:\/\/doi.org\/10.1002\/gcc.23238 (2024).","journal-title":"Genes Chromosomes Cancer"},{"issue":"4","key":"87027_CR32","doi-asserted-by":"publisher","first-page":"100224","DOI":"10.1016\/j.xhgg.2023.100224","volume":"4","author":"HC Beird","year":"2023","unstructured":"Beird, H. C. et al. Complete loss of TP53 and RB1 is associated with complex genome and low immune infiltrate in pleomorphic rhabdomyosarcoma. HGG Adv. 4(4), 100224. https:\/\/doi.org\/10.1016\/j.xhgg.2023.100224 (2023).","journal-title":"HGG Adv."},{"issue":"3","key":"87027_CR33","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1002\/gcc.23013","volume":"61","author":"ZL Chelsky","year":"2022","unstructured":"Chelsky, Z. L., Paulson, V. A. & Chen, E. Y. Molecular analysis of 10 pleomorphic rhabdomyosarcomas reveals potential prognostic markers and druggable targets. Genes Chromosomes Cancer 61(3), 138\u2013147 (2022).","journal-title":"Genes Chromosomes Cancer"},{"issue":"3","key":"87027_CR34","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/pbc.20795","volume":"48","author":"T Trahair","year":"2007","unstructured":"Trahair, T., Andrews, L. & Cohn, R. J. Recognition of Li Fraumeni syndrome at diagnosis of a locally advanced extremity rhabdomyosarcoma. Pediatr. Blood Cancer 48(3), 345\u2013348 (2007).","journal-title":"Pediatr. Blood Cancer"},{"issue":"4","key":"87027_CR35","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/S0092-8674(01)00245-8","volume":"104","author":"K Cichowski","year":"2021","unstructured":"Cichowski, K. & Jacks, T. NF1 tumor suppressor gene function: narrowing the GAP. Cell 104(4), 593\u2013604 (2021).","journal-title":"Cell"},{"key":"87027_CR36","doi-asserted-by":"publisher","first-page":"104547","DOI":"10.1016\/j.phrs.2019.104547","volume":"151","author":"L Mingxue","year":"2020","unstructured":"Mingxue, L. et al. Bcl-XL: a multifunctional anti-apoptotic protein. Pharmacol. Res. 151, 104547. https:\/\/doi.org\/10.1016\/j.phrs.2019.104547 (2020).","journal-title":"Pharmacol. Res."},{"key":"87027_CR37","doi-asserted-by":"publisher","first-page":"34513","DOI":"10.1038\/srep34513","volume":"6","author":"BX Li","year":"2016","unstructured":"Li, B. X. et al. Systemic inhibition of CREB is well-tolerated in vivo. Sci. Rep. 6, 34513. https:\/\/doi.org\/10.1038\/srep34513 (2016).","journal-title":"Sci. Rep."},{"issue":"4","key":"87027_CR38","doi-asserted-by":"publisher","first-page":"384","DOI":"10.2174\/156800910791208535","volume":"10","author":"X Xiao","year":"2010","unstructured":"Xiao, X., Li, B. X., Mitton, B., Ikeda, A. & Sakamoto, K. M. Targeting CREB for cancer therapy: friend or foe. Curr. Cancer Drug Targets 10(4), 384\u2013391 (2010).","journal-title":"Curr. Cancer Drug Targets"},{"issue":"1","key":"87027_CR39","doi-asserted-by":"publisher","first-page":"4297","DOI":"10.1038\/s41467-022-32023-7","volume":"13","author":"H Dorado Garcia","year":"2022","unstructured":"Dorado Garcia, H. et al. Therapeutic targeting of ATR in alveolar rhabdomyosarcoma. Nat. Commun. 13(1), 4297. https:\/\/doi.org\/10.1038\/s41467-022-32023-7 (2022).","journal-title":"Nat. Commun."},{"issue":"6","key":"87027_CR40","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.annonc.2022.03.011","volume":"33","author":"AS Venkataramany","year":"2022","unstructured":"Venkataramany, A. S. et al. Alternative RNA splicing defects in pediatric cancers: new insights in tumorigenesis and potential therapeutic vulnerabilities. Ann. Oncol. 33(6), 578\u2013592 (2022).","journal-title":"Ann. Oncol."},{"issue":"1","key":"87027_CR41","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41420-023-01777-4","volume":"10","author":"Y Chen","year":"2024","unstructured":"Chen, Y. et al. CHEK2 knockout is a therapeutic target for TP53-mutated hepatocellular carcinoma. Cell. Death Discov. 10(1), 37 (2024).","journal-title":"Cell. Death Discov"},{"key":"87027_CR42","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1002\/humu.24110","volume":"41","author":"G Vargas-Parra","year":"2020","unstructured":"Vargas-Parra, G. et al. Comprehensive analysis and ACMG-based classification of CHEK2 variants in hereditary cancer patients. Hum. Mutat. 41, 2128\u20132142 (2020).","journal-title":"Hum. Mutat."},{"key":"87027_CR43","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.3390\/cells9122675","volume":"9","author":"L Stolarova","year":"2020","unstructured":"Stolarova, L. et al. CHEK2 germline variants in cancer predisposition: stalemate rather than checkmate. Cells 9, 2675. https:\/\/doi.org\/10.3390\/cells9122675 (2020).","journal-title":"Cells"},{"issue":"1","key":"87027_CR44","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12863-022-01059-5","volume":"23","author":"H Wang","year":"2022","unstructured":"Wang, H., Wang, X., Xu, L. & Zhang, J. TP53 and TP53-associated genes are correlated with the prognosis of paediatric neuroblastoma. BMC Genom.  Data 23(1), 41 (2022).","journal-title":"BMC Genom. Data"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87027-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87027-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87027-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T02:43:52Z","timestamp":1737600232000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87027-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,23]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["87027"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-87027-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,23]]},"assertion":[{"value":"29 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2893"}}